Type of Therapy and Quality of Life in Atrial Fibrillation
Atrial fibrillation (AF) is a frequent and costly health care problem. In patients with AF, the restoration and maintenance of sinus rhythm is the primary therapeutic goal. The most frequent strategy for maintaining sinus rhythm after its restoration is the use of antiarrhythmic drugs. The efficacy of therapy in AF has been predominantly measured using objective criteria such as mortality and morbidity. In recent years, the importance of quality of life as an outcome measure has been recognized. However, few studies in the literature have examined quality of life in patients with AF using properly validated tools. In addition, the specific impact of antiarrhythmic treatment on quality of life in patients with AF has not been assessed. These issues are now being addressed in several ongoing studies. This article attempts to define quality of life, makes recommendations on how quality of life might be assessed, and reviews our current knowledge regarding quality of life in patients with AF.
KeywordsAtrial Fibrillation Sinus Rhythm Chronic Atrial Fibrillation Global Life Satisfaction Maintain Sinus Rhythm
Unable to display preview. Download preview PDF.
- 7.Jung W, Luderitz B (1998) Quality of life in patients with atrial fibrillation. J Cardiovasc Electrophysiol 9 [Suppl 8]:5177–5186Google Scholar
- 8.Crijns HJGM, Van Gelder IC, Tieleman RG, Gosselink ATM, Van den Berg MP (1997) Why is atrial fibrillation bad for you? In: Murgatroyd FD, Camm AJ (eds) Nonpharmacological management of atrial fibrillation. Futura, Armonk, pp 3–13Google Scholar
- 11.Wellens JJW, Lau CP, Luderitz B, Akhtar M, Waldo A, Camm AJ, Timmermans C, Tse HF, Jung W, Jordaens L, Ayers G, for the METRIX Investigators (1998) Atrioverter: an implantable device for the treatment of atrial fibrillation. Circulation 98:1651–1656Google Scholar
- 16.Twidale N, Sutton K, Bartlett L, Booley A, Winstanley S, Heddle W, Hassam R, Koutsounis H (1993) Effects on cardiac performance of atrioventricular node catheter ablation using radiofrequency current for drug-refractory atrial arrhythmias. Pacing Clin Electrophysiol 16:1275–1284PubMedCrossRefGoogle Scholar
- 17.Rodriguez LM, Smeets JL, Xie B, de Chillou C, Cherix E, Pieters F, Metzger J, den Dulk K, Wellens HJJ (1993) Improvement in left ventricular function by ablation of atrio-ventricular nodal conduction in selected patients with lone atrial fibrillation. Am J Cardiol 72:1137–1141PubMedCrossRefGoogle Scholar
- 18.Brignole M, Gionfranchi L, Menozzi C, Bottoni N, Bollini R, Lolli G, Oddone D, Giaggioli G (1994) Influence of atrioventricular junction radiofrequency ablation patients with chronic atrial fibrillation and flutter on quality of life and cardiac performance. Am J Cardiol 74:242–246PubMedCrossRefGoogle Scholar
- 20.Fitzpatrick AP, Kourouyan HD, Siu A, Lee RJ, Lesh MD, Epstein LM, Griffin JC, Scheinman NM (1996) Quality of life and outcomes after radiofrequency His-bundle catheter ablation and permanent pacemaker implantation: impact of treatment in paroxysmal and established atrial fibrillation. Am Heart J 131:499–507PubMedCrossRefGoogle Scholar
- 21.Natale A, Zimerman L, Tomassoni G, Kearney M, Kent V, Brandon MJ, Newby K (1996) Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response. Am J Cardiol 78:1431–1433PubMedCrossRefGoogle Scholar
- 22.Steinbeck G (1996) Drug therapy of atrial fibrillation: control of heart rate versus establishing sinus rhythm (in German). Z Kardiol 85[Suppl 61:69–74Google Scholar